116
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs

, , , , , , & show all
Pages 2205-2212 | Published online: 11 Oct 2011

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.